Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-23-147098
Filing Date
2023-05-17
Accepted
2023-05-17 17:01:30
Documents
12
Period of Report
2023-06-26

Document Format Files

Seq Description Document Type Size
1 DEF 14A d256418ddef14a.htm DEF 14A 791896
2 GRAPHIC g256418g00z01.jpg GRAPHIC 189732
3 GRAPHIC g256418g00z02.jpg GRAPHIC 162295
4 GRAPHIC g256418g01a06.jpg GRAPHIC 59632
5 GRAPHIC g256418g01p60.jpg GRAPHIC 340870
6 GRAPHIC g256418g01p61.jpg GRAPHIC 323781
7 GRAPHIC g256418g03w98.jpg GRAPHIC 30523
8 GRAPHIC g256418g04q37.jpg GRAPHIC 40498
9 GRAPHIC g256418g20j26.jpg GRAPHIC 43294
10 GRAPHIC g256418g25p13.jpg GRAPHIC 118899
11 GRAPHIC g256418g25q14.jpg GRAPHIC 117803
12 GRAPHIC g256418g27p19.jpg GRAPHIC 19723
  Complete submission text file 0001193125-23-147098.txt   2788004
Mailing Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431
Business Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431 561-961-1900
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

EIN.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-00100 | Film No.: 23932624
SIC: 2834 Pharmaceutical Preparations